Statement of Ownership (sc 13g)
March 31 2023 - 4:01PM
Edgar (US Regulatory)
Securities
and Exchange Commission
Washington,
DC 20549
SCHEDULE 13G
Under
the Securities Exchange Act of 1934
(Amendment
No. )*
Quince Therapeutics, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
22053A107
(CUSIP Number)
March 21, 2023
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
|
CUSIP No. 22053A107
|
13G |
Page
2 of 8 Pages |
| 1 |
NameS
of Reporting Persons
I.R.S. Identification NOS. of Above Persons (ENTITIES ONLY)
TANG
CAPITAL PARTNERS, LP
|
| 2 |
Check the Appropriate Box if a Member of a Group* |
(a)
¨
(b) ý |
| 3 |
SEC Use Only
|
| 4 |
Citizenship
or Place of Organization
DELAWARE
|
Number of
Shares
BENEFICIALLY
Owned by
Each Reporting
Person with |
5 |
Sole
Voting Power
0 |
| 6 |
Shared
Voting Power
3,620,000 |
| 7 |
Sole
Dispositive Power
0 |
| 8 |
Shared
Dispositive Power
3,620,000 |
| 9 |
Aggregate
Amount Beneficially Owned by each Reporting Person
3,620,000 |
| 10 |
Check
Box if the Aggregate Amount in Row (9) excludes certain shares
¨ |
| 11 |
Percent
of Class represented by amount in row 9
9.98% |
| 12 |
type
of reporting person
pN |
CUSIP
No. 22053A107
|
13G |
Page
3 of 8 Pages |
| 1 |
NameS
of Reporting Persons
I.R.S. Identification NOS. of Above Persons (ENTITIES ONLY)
Tang
Capital Management, LLC
|
| 2 |
Check the Appropriate Box if a Member of a Group* |
(a)
¨
(b) ý |
| 3 |
SEC
Use Only
|
| 4 |
Citizenship
or Place of Organization
DELAWARE
|
Number
of
Shares
BENEFICIALLY
Owned by
Each Reporting
Person with |
5 |
Sole
Voting Power
0 |
| 6 |
Shared
Voting Power
3,620,000 |
| 7 |
Sole
Dispositive Power
0 |
| 8 |
Shared
Dispositive Power
3,620,000 |
| 9 |
Aggregate
Amount Beneficially Owned by each Reporting Person
3,620,000 |
| 10 |
Check
Box if the Aggregate Amount in Row (9) excludes certain shares
¨ |
| 11 |
Percent
of Class represented by amount in row 9
9.98% |
| 12 |
type
of reporting person
OO |
|
CUSIP No. 22053A107
|
13G |
Page
4 of 8 Pages |
| 1 |
NameS
of Reporting Persons
I.R.S. Identification NOS. of Above Persons (ENTITIES ONLY)
KEVIN TANG
|
| 2 |
Check the Appropriate Box if a Member of a Group* |
(a)
¨
(b) ý |
| 3 |
SEC
Use Only
|
| 4 |
Citizenship
or Place of Organization
united
states
|
Number of
Shares
BENEFICIALLY
Owned by
Each Reporting
Person with |
5 |
Sole
Voting Power
0 |
| 6 |
Shared
Voting Power
3,620,000 |
| 7 |
Sole
Dispositive Power
0 |
| 8 |
Shared
Dispositive Power
3,620,000 |
| 9 |
Aggregate
Amount Beneficially Owned by each Reporting Person
3,620,000 |
| 10 |
Check
Box if the Aggregate Amount in Row (9) excludes certain shares
¨ |
| 11 |
Percent
of Class represented by amount in row 9
9.98% |
| 12 |
type
of reporting person
IN |
| Item 1(a). | Name of Issuer: |
Quince Therapeutics, Inc., a Delaware corporation (the “Issuer”)
| Item 1(b). | Address of Issuer’s Principal Executive Offices: |
601 Gateway Boulevard, Suite 1250, South San Francisco, CA 94080
| Item 2(a). | Name of Person Filing: |
This Statement on
Schedule 13G (this “Statement”) is filed by Tang Capital Partners, LP (“Tang Capital Partners”); Tang Capital
Management, LLC, the general partner of Tang Capital Partners (“Tang Capital Management”); and Kevin Tang, the manager
of Tang Capital Management.
| Item 2(b). | Address of Principal Business Office or, if none, Residence: |
4747 Executive Drive, Suite 210,
San Diego, CA 92121
Tang Capital Partners
is a Delaware limited partnership. Tang Capital Management is a Delaware limited liability company. Mr. Tang is a United States
citizen.
| Item 2(d). | Title of Class of Securities: |
Common Stock, par value
$0.001 per share (the “Common Stock”)
| Item 2(e). | CUSIP Number: 22053A107 |
| (a) | Amount Beneficially Owned: |
Tang Capital Partners. Tang Capital
Partners beneficially owns 3,620,000 shares of the Issuer’s Common Stock.
Tang Capital Partners shares voting and dispositive
power over such shares with Tang Capital Management and Kevin Tang.
Tang Capital Management. Tang Capital
Management beneficially owns 3,620,000 shares of the Issuer’s Common Stock.
Tang Capital Management shares voting and
dispositive power over such shares with Tang Capital Partners and Kevin Tang.
Kevin Tang. Kevin Tang beneficially
owns 3,620,000 shares of the Issuer’s Common Stock.
Kevin Tang shares voting and dispositive
power over such shares with Tang Capital Partners and Tang Capital Management.
The percentages used herein are based on
36,276,945 shares of Common Stock outstanding as of March 10, 2023, as set forth in the Issuer’s Annual Report filed on Form 10-K
that was filed with the Securities and Exchange Commission on March 15, 2023.
| Tang Capital Partners |
9.98% |
| Tang Capital Management |
9.98% |
| Kevin Tang |
9.98% |
| (c) | Number of shares as to which such person has: |
(i) sole
power to vote or to direct the vote:
| Tang Capital Partners |
0 shares |
| Tang Capital Management |
0 shares |
| Kevin Tang |
0 shares |
(ii) shared
power to vote or to direct the vote:
| Tang Capital Partners |
3,620,000 shares |
| Tang Capital Management |
3,620,000 shares |
| Kevin Tang |
3,620,000 shares |
(iii) sole
power to dispose or to direct the disposition of:
| Tang Capital Partners |
0 shares |
| Tang Capital Management |
0 shares |
| Kevin Tang |
0 shares |
(iv) shared
power to dispose or to direct the disposition of:
| Tang Capital Partners |
3,620,000 shares |
| Tang Capital Management |
3,620,000 shares |
| Kevin Tang |
3,620,000 shares |
| Item 5. | Ownership of Five Percent or Less of a Class. |
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the following: o
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not applicable
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported
on by the Parent Holding Company. |
Not applicable.
| Item 8. | Identification and Classification of Members of the Group. |
Not applicable.
| Item 9. | Notice of Dissolution of Group. |
Not applicable.
By signing below I certify that,
to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of
or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purpose or effect.
Signature
After reasonable inquiry and to the best of
my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| Date: |
March 31, 2023 |
|
| |
|
|
| |
|
|
| TANG CAPITAL PARTNERS, LP |
|
| |
|
|
| By: |
Tang Capital Management, LLC, its General Partner |
|
| |
|
|
| |
|
|
| By: |
/s/ Kevin Tang |
|
| |
Kevin Tang, Manager |
|
| |
|
|
| |
|
|
| TANG CAPITAL MANAGEMENT, LLC |
| |
|
|
| |
|
|
| By: |
/s/ Kevin Tang |
|
| |
Kevin Tang, Manager |
|
| |
|
|
| |
|
|
| /s/ Kevin Tang |
|
| Kevin Tang |
|
Page 8 of 8 Pages
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Nov 2024 to Dec 2024
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Dec 2023 to Dec 2024
